Trial intelligence / Profile preview

Long-term safety and efficacy of calcitriol ointment in pediatric plaque psoriasis

2014-000710-53Phase 3Completed

Sponsor
Galderma
Start
Oct 2014
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, open-label, single-arm trial of calcitriol in plaque psoriasis, sponsored by Galderma. Primary endpoints: Long-term safety of calcitriol ointment and Clinical efficacy of calcitriol ointment. Started Oct 2014; status: completed.

02

Drugs

calcitriol
03

Conditions

plaque psoriasis

Beyond the preview

Go deeper on 2014-000710-53.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2014-000710-53.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call